Women, doctors speak about breast implant illnesses at FDA hearing

इंडिया समाचार समाचार

Women, doctors speak about breast implant illnesses at FDA hearing
इंडिया ताज़ा खबर,इंडिया मुख्य बातें
  • 📰 NBCNews
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 86%

The FDA is reviewing the safety of breast implants used by millions of American women at a 2-day hearing about their long-term potential health effects.

used by millions of American women at a two-day hearing about their long-term potential health effects.

Criss implored the FDA panel to ban textured breast implants. “Cancer was not a choice,” she said. “And we sure as heck didn’t elect to get it.” There was wide agreement at the meeting for the need for better surveillance of breast implant problems. Earlier this month, FDA commissioner Dr. Scott Gottlieb and Dr. Jeff Shuren of the Center for Devices and Radiological Health, released a statement on breast implant safety, addressing the need for breast implant registries to follow patients with BIA-ALCL.

Breast augmentation is the most popular form of cosmetic surgery in the U.S., with over 300,000 women undergoing the procedure each year, according to the American Society of Plastic Surgeons. Another 100,000 women undergo breast reconstruction after mastectomy.

हमने इस समाचार को संक्षेप में प्रस्तुत किया है ताकि आप इसे तुरंत पढ़ सकें। यदि आप समाचार में रुचि रखते हैं, तो आप पूरा पाठ यहां पढ़ सकते हैं। और पढो:

NBCNews /  🏆 10. in US

इंडिया ताज़ा खबर, इंडिया मुख्य बातें

Similar News:आप इससे मिलती-जुलती खबरें भी पढ़ सकते हैं जिन्हें हमने अन्य समाचार स्रोतों से एकत्र किया है।

Sage Therapeutics’ Drug for Postpartum Depression Gets FDA NodSage Therapeutics’ Drug for Postpartum Depression Gets FDA NodU.S. health regulators on Tuesday approved Sage Therapeutics Inc.’s Zulresso, the first medication specifically intended for women with postpartum depression.
और पढो »

FDA approves new device for treating patients with chronic heart failureFDA approves new device for treating patients with chronic heart failureThe Food and Drug Administration approved a breakthrough medical device last week for patients suffering from chronic, hard-to-treat heart failure.
और पढो »

Women in New Zealand are donning a 'headscarf for harmony' to remember the mosque shooting victimsWomen in New Zealand are donning a 'headscarf for harmony' to remember the mosque shooting victimsCNN News, delivered. Select from our newsletters below and enter your email to subscribe.
और पढो »

New Zealand women don headscarves to support Muslims after shootingsNew Zealand women don headscarves to support Muslims after shootingsWomen all over New Zealand put on headscarves on Friday to show solidarity with ...
और पढो »

Women in New Zealand are donning headscarves to remember mosque shooting victimsWomen in New Zealand are donning headscarves to remember mosque shooting victimsOne week ago, a gunman made his way into two mosques in Christchurch, New Zealand, killing 50 people. Today, women across the country are wearing a headscarf similar to a traditional hijab worn by Muslim women to show support for victims and the religion.
और पढो »

New Zealand Women Wore Headscarves To Support The Muslim CommunityNew Zealand Women Wore Headscarves To Support The Muslim CommunityA doctor in Auckland, Thaya Ashman, came up with the Headscarf for Harmony idea after hearing that a woman had been too scared to go out in public in hijab.
और पढो »

Are women COOs facing a new kind of glass ceiling?Are women COOs facing a new kind of glass ceiling?“Does the COO role risk becoming a glass ceiling… a position from which accomplished women leaders stoke the industry’s growth, in a perpetual supporting role, without breaking into the CEO boys’ club?” Leigh Gallagher. WomensHistoryMonth
और पढो »

FDA says cybersecurity vulnerabilities found in some Medtronic devicesFDA says cybersecurity vulnerabilities found in some Medtronic devicesThe U.S. Food and Drug Administration (FDA) on Thursday said cybersecurity vulne...
और पढो »

FDA rejects Sanofi-Lexicon add-on pill for type 1 diabetesFDA rejects Sanofi-Lexicon add-on pill for type 1 diabetesThe U.S. Food and Drug Administration declined to approve a drug developed by Sa...
और पढो »



Render Time: 2025-02-27 19:01:35